MBAI
NASDAQ
Health Care
$1.00
USD
$0.00 (0.00%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$7.30M
Volume:
12.2K
Previous Close
$1.00
Day Range
$0.99 - $1.02
52 Week Range
$0.99 - $3.92
Average Volume (10 Days)
70.0K
P/E Ratio (TTM)
0.78
Dividend Yield
—
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Check Cap Ltd develops C-Scan, a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. Its capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps and other structural abnormalities. C-Scan is a non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
CEO
Mr. Alex Ovadia
Headquaters
Isfiya, Haifa, IL
Founded
2015
Employees
85